Insiders · SLRX

SLRX insider transactions

Salarius Pharmaceuticals Inc. (SLRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for SLRX

• 156d
  Director Hanish Arnold C sold $17 worth of shares (27 units at $0.64), closing all direct ownership in the company (SEC Form 4)

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 195d
  Director Hanish Arnold C bought $3,740 worth of shares (5,000 units at $0.75) (SEC Form 4)

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 199d
  Exec VP Finance, CFO Rosenblum Mark J bought $16,000 worth of shares (20,000 units at $0.80), increasing direct ownership by 11,299% to 20,177 units (SEC Form 4)

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 786d
  SEC Form 4 filed by Arthur David J.

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 836d
  SEC Form 4 filed by Rosenblum Mark J

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 836d
  SEC Form 4 filed by Mcvicar William K.

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 836d
  SEC Form 4 filed by Mccreedy Bruce J Jr.

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 836d
  SEC Form 4 filed by Lieber Jonathan I

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 836d
  SEC Form 4 filed by Lammers Paul

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 836d
  SEC Form 4 filed by Burleson Tess

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 836d
  SEC Form 4 filed by Hanish Arnold C

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1208d
  SEC Form 4: Rosenblum Mark J was granted 6,432 shares, increasing direct ownership by 42% to 21,851 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1208d
  SEC Form 4: Arthur David J. was granted 14,300 shares, increasing direct ownership by 42% to 48,019 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1249d
  SEC Form 4: Lieber Jonathan I was granted 1,440 shares, increasing direct ownership by 96% to 2,940 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1249d
  SEC Form 4: Mccreedy Bruce J Jr. was granted 1,440 shares, increasing direct ownership by 414% to 1,788 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1249d
  SEC Form 4: Hanish Arnold C was granted 1,440 shares

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1249d
  SEC Form 4: Lammers Paul was granted 1,440 shares, increasing direct ownership by 518% to 1,718 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1249d
  SEC Form 4: Burleson Tess was granted 1,440 shares, increasing direct ownership by 112% to 2,722 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1249d
  SEC Form 4: Mcvicar William K. was granted 1,440 shares, increasing direct ownership by 414% to 1,788 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1249d
  SEC Form 4: Rosenblum Mark J was granted 8,000 shares, increasing direct ownership by 108% to 15,419 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1249d
  SEC Form 4: Arthur David J. was granted 20,000 shares, increasing direct ownership by 146% to 33,719 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1273d
  SEC Form 4: Arthur David J. was granted 2,693 shares, increasing direct ownership by 24% to 13,719 units (Amendment)

  4/A - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1273d
  SEC Form 4: Rosenblum Mark J was granted 1,488 shares, increasing direct ownership by 25% to 7,419 units (Amendment)

  4/A - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1307d
  SEC Form 4: Arthur David J. was granted 10,000 shares, increasing direct ownership by 91% to 21,026 units (Amendment)

  4/A - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1307d
  SEC Form 4: Rosenblum Mark J was granted 7,314 shares, increasing direct ownership by 123% to 13,245 units (Amendment)

  4/A - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1308d
  SEC Form 4: Arthur David J. was granted 10,000 shares, increasing direct ownership by 4% to 285,674 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1308d
  SEC Form 4: Rosenblum Mark J was granted 7,314 shares, increasing direct ownership by 5% to 155,633 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1461d
  SEC Form 4: Burleson Tess bought $4,986 worth of shares (27,700 units at $0.18), increasing direct ownership by 637% to 32,050 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1461d
  SEC Form 4: Lieber Jonathan I bought $7,016 worth of shares (37,500 units at $0.19)

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1461d
  SEC Form 4: Mcvicar William K. bought $5,000 worth of shares (26,553 units at $0.19)

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1462d
  SEC Form 4: Hanish Arnold C bought $5,152 worth of shares (28,000 units at $0.18)

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1462d
  SEC Form 4: Hanish Arnold C bought $3,920 worth of shares (4,000 units at $0.98) (Amendment)

  4/A - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1462d
  SEC Form 4: Hanish Arnold C bought $5,002 worth of shares (4,350 units at $1.15) (Amendment)

  4/A - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1462d
  SEC Form 4: Hanish Arnold C bought $10,770 worth of shares (3,000 units at $3.59) (Amendment)

  4/A - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1468d
  SEC Form 4: Arthur David J. bought $7,985 worth of shares (43,900 units at $0.18), increasing direct ownership by 8% to 281,674 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1468d
  SEC Form 4: Rosenblum Mark J bought $5,040 worth of shares (28,000 units at $0.18), increasing direct ownership by 23% to 148,319 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1494d
  SEC Form 4: Rosenblum Mark J was granted 10,000 shares, increasing direct ownership by 9% to 120,319 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1551d
  SEC Form 4: Rosenblum Mark J bought $29,812 worth of shares (76,246 units at $0.39), increasing direct ownership by 224% to 110,319 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1551d
  SEC Form 4: Arthur David J. bought $54,540 worth of shares (139,488 units at $0.39), increasing direct ownership by 127% to 249,674 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1598d
  SEC Form 4 filed by Mccreedy Bruce J Jr.

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1598d
  SEC Form 4 filed by Lieber Jonathan I

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1598d
  SEC Form 4 filed by Mcvicar William K.

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1598d
  SEC Form 4 filed by Arthur David J.

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1598d
  SEC Form 4 filed by Burleson Tess

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1598d
  SEC Form 4 filed by Hanish Arnold C

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1598d
  SEC Form 4 filed by Lammers Paul

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1598d
  SEC Form 4 filed by Rosenblum Mark J

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1676d
  SEC Form 4: Arthur David J. was granted 7,939 shares, increasing direct ownership by 8% to 110,186 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1676d
  SEC Form 4: Rosenblum Mark J was granted 7,787 shares, increasing direct ownership by 30% to 34,073 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1755d
  SEC Form 4 filed by Salarius Pharmaceuticals, Inc.

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1761d
  SEC Form 4 filed by Salarius Pharmaceuticals, Inc.

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1859d
  SEC Form 4: Rosenblum Mark J was granted 9,563 units of Common Stock, increasing direct ownership by 57% to 26,286 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)
• 1859d
  SEC Form 4: Arthur David J. was granted 9,822 units of Common Stock, increasing direct ownership by 11% to 96,247 units

  4 - Salarius Pharmaceuticals, Inc. (0001615219) (Issuer)